| 1 |
33177877 | Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer. | 2020 |
5 |
| 2 |
31285549 | KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner. | 2019 Aug |
1 |
| 3 |
23816136 | miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O. | 2013 Aug |
2 |
| 4 |
21821547 | Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers. | 2012 Apr |
1 |
| 5 |
17290426 | G2/M checkpoint gene expression in developing germ cells. | 2007 May |
1 |
| 6 |
15342418 | P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells. | 2004 Sep 1 |
1 |
| 7 |
12973835 | ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression. | 2003 Sep 15 |
1 |
| 8 |
9743457 | Cisplatin-induced inhibition of p34cdc2 is abolished by 5-fluorouracil. | 1998 |
1 |